tiprankstipranks
Sangamo Therapeutics (SGMO)
NASDAQ:SGMO
SGMO
Sangamo Therapeutics
RESEARCH TOOLSreports

Sangamo Therapeutics (SGMO) Revenue

2,624 Followers
StatisticsMarket CapRevenue

Sangamo Therapeutics Revenue

Sangamo Therapeutics had a revenue of 14.23M in the quarter ending Dec 31, 2025, with 2348.88%. This bring the company's revenue in the last twelve months to 39.55M, Decreased 20.31%. In the fiscal year ending Dec 31, 2025, Sangamo Therapeutics had annual revenue of 39.55M with -31.57% growth.
Revenue (ttm)
39.55M
Revenue Growth
-37.13%
P/S Ratio
3.14
Revenue/Employee
$216,131
Employees
183
Market Cap
$124.32M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
39.55M-18.25M-31.57%
Dec 31, 2024
57.80M-118.43M-67.20%
Dec 31, 2023
176.23M64.93M+58.34%
Dec 31, 2022
111.30M598.00K+0.54%
Dec 31, 2021
110.70M-7.49M-6.34%
Dec 31, 2020
118.19M15.76M+15.39%
Dec 31, 2019
102.43M17.98M+21.29%
Dec 31, 2018
84.45M47.88M+130.95%
Dec 31, 2017
36.57M――